Inovio Biomedical Corporation - Financial and Strategic Analysis Review

Inovio Biomedical Corporation - Financial and Strategic Analysis Review

Summary

Global Markets Direct’s “Inovio Biomedical Corporation - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of Inovio Biomedical Corporation The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Inovio Biomedical Corporation (Inovio) is a biomedical company, engaged in the development of DNA-based vaccines and immunotherapies using its proprietary Electroporation Therapy (EPT) technology, for the treatment of treat cancer and chronic infectious diseases. Currently, it is developing two main franchises based on its MedPulser Electroporation System namely, Oncology and DNA vaccines. The company is headquartered in California, the US. On June 1, 2009, Inovio Biomedical Corporation completed the merger agreement with VGX Pharmaceuticals, Inc.(formerly known as Viral Genomix, Inc.) to form a leading vaccine discovery, development and delivery company.

Recent Developments

Oct 05, 2009: Inovio Reports Immunogenicity Data From Cervical Cancer Vaccine Trial
Oct 15, 2009: Inovio Initiates Phase I Clinical Trial For Pennvax-B
Oct 26, 2009: Inovio Elects David Williams And Keith Wells To Its Board

Scope

• Provides key company information for business intelligence needs
• The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick “one-stop-shop” to understand the company.
• Enhance business/sales activities by understanding customers’ businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors’ weaknesses and target the market opportunities available to them.
• Compare your company’s financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.